Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cresco Labs (DE:6CQ)
FRANKFURT:6CQ
Cresco Labs (6CQ) Stock Price & Analysis
2 Followers
6CQ Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.89 - €2.60
Previous Close€1.61
Volume0.00
Average Volume (3M)867.00
Market Cap
€720.21M
Enterprise Value€1.17B
Total Cash (Recent Filing)$123.16M
Total Debt (Recent Filing)$693.02M
Price to Earnings (P/E)―
Beta0.94
Next Earnings
Aug 14, 2024EPS Estimate
€0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.43
Shares Outstanding437,685,014
10 Day Avg. Volume374
30 Day Avg. Volume867
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)-9.20
Price to Sales (P/S)0.60
Price to Cash Flow (P/CF)4.70
P/FCF Ratio6.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.53
Enterprise Value/Gross Profit3.22
Enterprise Value/Ebitda83.84
Forecast
1Y Price Target
€4.78Price Target Upside197.27% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
Cresco Labs News
PremiumCompany Announcements
Cresco Labs Elects New Board, Enhances Incentive Plan
PremiumCompany Announcements
Cresco Labs Triumphs with Strong Q1 Financials
PremiumCompany Announcements
Cresco Labs Announces Q1 2024 Earnings Date
Bulls Say, Bears Say
Bulls Say
Cost ManagementThe Company reduced SG&A costs by 4.9% q/q, even while maintaining the #1 position in core markets such as IL, PA and MA, and as transactions grew by 4% y/y.
Growth DriversCresco has a compelling pipeline of growth drivers including the launch of adult-use sales in Ohio, the potential for Florida and Pennsylvania to convert to an adult-use market, the ramp up of New York’s adult-use program, and entering new state markets likely through M&A.
Strategy And Financial PerformanceThe Company's revised strategy which focuses on profitable growth in core markets and making improvements to its manufacturing assets to produce high quality cannabis products at low cost is bearing fruit.
Bears Say
Capital ExpendituresManagement introduced a capex guidance of $50-70M, significantly higher than previous estimates, suggesting lower free cash flow generation for the rest of the year.
Revenue OutlookA modest decline in revenue is expected, which could impact investor sentiment and stock performance.
Sales ProjectionsManagement maintained a conservative outlook for 2024, forecasting flat sales in the upcoming quarters before any potential growth.
---
Options Prices
Currently, No data available
---
Ownership Overview
57.53% Insiders
1.65% Mutual Funds
0.52% Other Institutional Investors
40.30% Public Companies and
Individual Investors
6CQ FAQ
What was Cresco Labs’s price range in the past 12 months?
Cresco Labs lowest stock price was €0.89 and its highest was €2.60 in the past 12 months.
What is Cresco Labs’s market cap?
Currently, no data Available
When is Cresco Labs’s upcoming earnings report date?
Cresco Labs’s upcoming earnings report date is Aug 14, 2024 which is in 25 days.
How were Cresco Labs’s earnings last quarter?
Cresco Labs released its earnings results on May 15, 2024. The company reported -€0.009 earnings per share for the quarter, beating the consensus estimate of -€0.018 by €0.009.
Is Cresco Labs overvalued?
According to Wall Street analysts Cresco Labs’s price is currently Undervalued.
Does Cresco Labs pay dividends?
Cresco Labs does not currently pay dividends.
What is Cresco Labs’s EPS estimate?
Cresco Labs’s EPS estimate is €0.02.
How many shares outstanding does Cresco Labs have?
Cresco Labs has 328,586,640 shares outstanding.
What happened to Cresco Labs’s price movement after its last earnings report?
Cresco Labs reported an EPS of -€0.009 in its last earnings report, beating expectations of -€0.018. Following the earnings report the stock price went up 1.081%.
Which hedge fund is a major shareholder of Cresco Labs?
Currently, no hedge funds are holding shares in DE:6CQ
---
Cresco Labs Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€4.78 (197.27% Upside)
€4.78 (197.27% Upside)
Blogger Sentiment
Bullish
DE:6CQ Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Sold Shares
Worth $554.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-2.31%
12-Months-Change
Fundamentals
Return on Equity
-27.50%
Trailing 12-Months
Asset Growth
-12.29%
Trailing 12-Months
Company Description
Cresco Labs
Cresco Labs Inc is a Canada based company engaged in the production and sale of cannabis. The company distribute its products to dispensaries nationwide, including several dispensaries owned and operated by its team. Its product includes Reserve, Remedi, Mindy's. All the revenues of the company were generated in the United States. It has ownership interests in Illinois, Pennsylvania, Ohio, California, Maryland, and Arizona.
---
6CQ Company Deck
---
6CQ Earnings Call
Q1 2024
0:00 / 0:00
---
6CQ Stock 12 Month Forecast
Average Price Target
€4.78
▲(197.27% Upside)
Technical Analysis
Cresco Labs
―
Green Thumb Industries
―
Curaleaf Holdings
―
Trulieve Cannabis
―
Ayr Wellness
―
Best Analysts Covering 6CQ
1 Year
1 Year Success Rate
9/24 ratings generated profit
1 Year Average Return
+11.00%
reiterated a buy rating 2 months ago
Copying Derek Dley's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of +11.00% per trade.
---